NDC 0409-1810 - Novocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1810
- Package NDCs from labels
- 0409-1810-02
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-08-28 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1810-02 | Novocaine | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 2 | |
| 0409-1810-02 | Novocaine | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 2 | |
| 0409-1810-02 | Novocaine | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Acetate | POTASSIUM ACETATE | Hospira, Inc. | c7eabefd-2781-439b-b8f4-cb3ea25a4720 | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | e18ed1cb-7dd0-4001-bfda-17d1f4587fb8 | 2026-04-27 | Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate | MAGNESIUM SULFATE | Hospira, Inc. | d4b5863a-efb9-4551-a9ad-2b06e8666d87 | 2026-04-23 | Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | 1d181906-f3ec-4222-1883-e61577a3122e | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | Hospira, Inc. |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | 3832ede8-d3fc-455d-ecab-3b77be5869f5 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| ROCURONIUM BROMIDE | ROCURONIUM BROMIDE | Hospira, Inc. | cccd40ca-5f08-4acb-8548-3cad558388bb | 2026-04-15 | Warnings, Adverse reactions | Hospira, Inc. |
| Midazolam | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | affecd4d-1f78-4bbe-5a8d-86849bbdc520 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| MANGANESE | MANGANESE CHLORIDE | Hospira, Inc. | 6e979070-5035-4076-e09c-b52466be3c68 | 2026-04-15 | Warnings, Adverse reactions | Hospira, Inc. |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | bb44c7e1-d911-4788-908f-09b7b271969b | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| TOBRAMYCIN | TOBRAMYCIN | Hospira, Inc. | c5a005b0-7b6f-4e30-df92-9a20b1ca66a1 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Potassium Acetate | POTASSIUM ACETATE | Hospira, Inc. | 8123cce8-42e3-49e4-a488-3bb836ecccd0 | 2026-04-09 | Warnings, Adverse reactions | Hospira, Inc. |
| FENTANYL CITRATE | FENTANYL CITRATE | Hospira, Inc. | 1ed25b2c-334e-4021-ada1-3396f07630dc | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Bupivacaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 7a8d2539-4422-4312-0298-207ef1a2948e | 2026-04-07 | Warnings, Adverse reactions | Hospira, Inc. |
| Deferoxamine Mesylate | DEFEROXAMINE MESYLATE | Hospira, Inc. | f9ab6b1c-98d0-4373-0e9b-b10cb4a67543 | 2026-04-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | Hospira, Inc. |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | 376093e7-e09e-4a57-3199-195e45251866 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | f2901045-904f-47bd-74a1-c561facd7f25 | 2026-04-01 | Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.